Fairfield, Bush & Co.
- SEC CIK
- 0001116247
- Latest filing
- Aug 13, 2026
ABBV holding history
AbbVie Inc. in every 13F filed by Fairfield, Bush & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings
- Shares (Q2 2026)
- 7,031
- Value
- $1.77M
- % of portfolio
- 0.9%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 7,031 | $1.77M | 0.9% | +276+4.1% | Added | Holders |
| Q1 2026 | 6,755 | $1.47M | 0.8% | −141−2.0% | Reduced | Holders |
| Q4 2025 | 6,896 | $1.58M | 0.8% | +729+11.8% | Added | Holders |
| Q3 2025 | 6,167 | $1.43M | 0.7% | +152+2.5% | Added | Holders |
| Q2 2025 | 6,015 | $1.12M | 0.6% | −16−0.3% | Reduced | Holders |
| Q1 2025 | 6,031 | $1.26M | 0.8% | −218−3.5% | Reduced | Holders |
| Q4 2024 | 6,249 | $1.11M | 0.7% | +2,739+78.0% | Added | Holders |
| Q3 2024 | 3,510 | $693.2K | 0.4% | +335+10.6% | Added | Holders |
| Q2 2024 | 3,175 | $544.6K | 0.3% | −943−22.9% | Reduced | Holders |
| Q1 2024 | 4,118 | $749.9K | 0.4% | −773−15.8% | Reduced | Holders |
| Q4 2023 | 4,891 | $758.0K | 0.4% | −388−7.3% | Reduced | Holders |
| Q3 2023 | 5,279 | $786.9K | 0.5% | −198−3.6% | Reduced | Holders |
| Q2 2023 | 5,477 | $737.9K | 0.2% | −222−3.9% | Reduced | Holders |
| Q1 2023 | 5,699 | $908.3K | 0.3% | −923−13.9% | Reduced | Holders |
| Q4 2022 | 6,622 | $1.07M | 0.7% | −48−0.7% | Reduced | Holders |
| Q3 2022 | 6,670 | $895.0K | 0.6% | +834+14.3% | Added | Holders |
| Q2 2022 | 5,836 | $894.0K | 0.5% | −2,868−33.0% | Reduced | Holders |
| Q1 2022 | 8,704 | $1.41M | 0.7% | −667−7.1% | Reduced | Holders |
| Q4 2021 | 9,371 | $1.27M | 0.6% | +972+11.6% | Added | Holders |
| Q3 2021 | 8,399 | $906.0K | 0.3% | +2,435+40.8% | Added | Holders |
| Q2 2021 | 5,964 | $671.0K | 0.2% | +400+7.2% | Added | Holders |
| Q1 2021 | 5,564 | $602.0K | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.